You searched for "patient"
Combined anti-VEGF and PDT for wet AMD
The authors report on a retrospective case series of combined anti-VEGF and photodynamic therapy (PDT) in the treatment of wet age-related macular degeneration (AMD) refractory to anti-VEGF monotherapy alone. The criteria for treatment failure of anti-VEGF monotherapy were persistent subretinal...Regulatory approval for the use of AI as a medical device
A study led by researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology examined 36 ‘artificial intelligence as a medical device’ tools approved by regulators in Australia, Europe and the US, identifying that 19% had no published peer-reviewed data...A focus on Pakistan’s growing eye care needs: over 43 million patients treated for curable blindness free of charge
With 90% of the world’s visually impaired living in developing countries, Pakistan is no exception to this on-going global healthcare challenge. Despite massive leaps over the last few decades in targeting this issue, the World Health Organisation (WHO) reports that...Survey of current undergraduate ophthalmology teaching in the United Kingdom
Is there a crisis in ophthalmic education? The British Undergraduate Ophthalmology Society surveyed medical students and junior doctors to evaluate current ophthalmology teaching across medical schools in the UK. British medicals schools are currently not obligated to include ophthalmology within...Artists Unite: hear from artist Lindsey Whitelaw
An art exhibition examining sight loss opened as part of the Wandsworth Arts Fringe in London on 10 June. Artist Lindsey Whitelaw spoke to Eye News about her process, and the influence of visual impairment on her work.The TOPCON / OIA Imaging Competition and a brief history of ophthalmic photography
We hope you like and appreciate the image forming the cover of the June/July 2021 edition of Eye News. The Ophthalmic Imaging Association (OIA) was honoured to have been invited to submit a series of images from the winners of...Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...South-South collaboration for the treatment of avoidable blindness in Botswana
This article describes the value of South-South collaboration in the reduction of avoidable blindness. Specifically it describes a South-South collaboration between India and Botswana that evolved out of the VISION 2020 LINK between Cambridge University Hospitals, two institutions in India...Moorfields Education: Glaucoma level 3 (College of Optometrists Professional Diploma in Glaucoma) 2025
This course is designed to build up from levels 1 and 2 to further develop skills in detecting change in clinical status and decision-making in patients with established glaucoma of all types in adult patients. Entry requirementsPossess a minimum of...
Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...
Long-term specular microscopy following Nd: YAG iridotomy in chronic POAG
The aim of this study was to evaluate specular microscopy of chronic primary angle-closure glaucoma (CPACG) eyes at least one year after Nd:YAG iridotomy, and compare them with CPACG eyes without an iridotomy and age-matched, normal eyes. Nd:YAG laser causes...
